Exceptionally High Payload of Doxorubicin in Hollow Gold Nanospheres for Near-Infrared Light-Triggered Drug Release
Source abstract
Abstract
We report dual-functional hollow gold nanospheres (HAuNS, approximately 40-nm diameter) capable of mediating both photothermal ablation of cancer cells and drug release upon near-infrared (NIR) light irradiation. As high as 63% DOX by weight ( approximately 1.7 microg DOX/microg Au) could be loaded to polyethylene glycol (PEG)-coated HAuNS since DOX was coated to both the outer and the inner surfaces of HAuNS. Irradiation with NIR laser induced photothermal conversion, which triggered rapid DOX release from DOX-loaded HAuNS. The release of DOX was also pH-dependent, with more DOX released in aqueous solution at lower pH. Significantly greater cell killing was observed when MDA-MB-231 cells incubated with DOX-loaded HAuNS were irradiated with NIR light, attributable to both HAuNS-mediated photothermal ablation and cytotoxicity of released free DOX.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Advanced biosensing and bioanalysis techniques · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Experimental Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
References (35)
Show source-provided references
1. Davis S. S. · Adv. Drug Delivery Rev. · 2004 · 56 · 124110.1016/j.addr.2004.02.001 ↗
2. Nishiyama N. · Pharmacol. Ther. · 2006 · 112 · 63010.1016/j.pharmthera.2006.05.006 ↗
3. Li C. · Adv. Drug Delivery Rev. · 2008 · 60 · 88610.1016/j.addr.2007.11.009 ↗
4. Alexiou C. · Cancer Res. · 2000 · 60 · 6641
5. Jain T. K. · Mol. Pharm. · 2005 · 2 · 19410.1021/mp0500014 ↗
6. Murakami T. · Mol. Pharm. · 2004 · 1 · 39910.1021/mp049928e ↗
7. Ajima K. · Mol. Pharm. · 2005 · 2 · 47510.1021/mp0500566 ↗
8. Liu Z. · Cancer Res. · 2008 · 68 · 665210.1158/0008-5472.CAN-08-1468 ↗
9. Dhar S. · J. Am. Chem. Soc. · 2008 · 130 · 1146710.1021/ja803036e ↗
10. Feazell R. P. · J. Am. Chem. Soc. · 2007 · 129 · 843810.1021/ja073231f ↗
11. Liu Z. · ACS Nano · 2007 · 1 · 5010.1021/nn700040t ↗
12. Templeton A. C. · Acc. Chem. Res. · 2000 · 33 · 2710.1021/ar9602664 ↗
13. De M. · Adv. Mater. · 2008 · 20 · 422510.1002/adma.200703183 ↗
14. Bhattacharya R. · Adv. Drug Delivery Rev. · 2008 · 60 · 128910.1016/j.addr.2008.03.013 ↗
15. Connor E. E. · Small · 2005 · 1 · 32510.1002/smll.200400093 ↗
16. Cheng M. M. · Curr. Opin. Chem. Biol. · 2006 · 10 · 1110.1016/j.cbpa.2006.01.006 ↗
17. Rosi N. L. · Chem. Rev. · 2005 · 105 · 154710.1021/cr030067f ↗
18. Baptista P. · Anal. Bioanal. Chem. · 2008 · 391 · 94310.1007/s00216-007-1768-z ↗
19. Gibson J. D. · J. Am. Chem. Soc. · 2007 · 129 · 1165310.1021/ja075181k ↗
20. Cheng Y. · J. Am. Chem. Soc. · 2008 · 130 · 1064310.1021/ja801631c ↗
21. Kim C. K. · J. Am. Chem. Soc. · 2009 · 131 · 136010.1021/ja808137c ↗
22. Chithrani B. D. · Nano Lett · 2007 · 7 · 154210.1021/nl070363y ↗
23. Visaria R. K. · Mol. Cancer Ther. · 2006 · 5 · 101410.1158/1535-7163.MCT-05-0381 ↗
24. Ghosh P. S. · ACS Nano · 2008 · 2 · 221310.1021/nn800507t ↗
25. Lee J. S. · Nano Lett. · 2009 · 9 · 240210.1021/nl9009793 ↗
26. Elbakry A. · Nano Lett. · 2009 · 9 · 205910.1021/nl9003865 ↗
27. Dhar S. · Chemistry · 2008 · 14 · 1024410.1002/chem.200801093 ↗
28. Kumar S. A. · Nanotechnology · 2008 · 19 · 49510110.1088/0957-4484/19/49/495101 ↗
29. Melancon M. P. · Mol Cancer Ther. · 2008 · 7 · 173010.1158/1535-7163.MCT-08-0016 ↗
30. Lu W. · Clin. Cancer Res. · 2009 · 15 · 87610.1158/1078-0432.CCR-08-1480 ↗
31. Schwartzberg A. M. · J. Phys. Chem. B · 2006 · 110 · 1993510.1021/jp062136a ↗
32. Fan C. · Proc. Natl. Acad. Sci. U.S.A. · 2003 · 100 · 629710.1073/pnas.1132025100 ↗
33. Peer D. · Nat. Nanotechnol. · 2007 · 2 · 75110.1038/nnano.2007.387 ↗
34. Maxfield F. R. · Nat. Rev. Mol. Cell. Biol. · 2004 · 5 · 12110.1038/nrm1315 ↗
35. Ji X. J. · J. Phys. Chem. C · 2007 · 111 · 6245